Screen Shot 2017-10-25 at 21.44.48.png
 

We were honored to have as our keynote speaker, Dr. Anthony Letai, a pioneer of Precision, Personalized and Functional Oncology. Dr. Letai presented his latest research and innovations in the use of functional genomics in treating cancer. You can watch his presentation, and those of other speakers, in the respective videos below. Plans are underway for Cancer Think Tank 3.0 to be held in the Winter of 2020.


Speakers

 
 Dr. Anthony Letai, MD, PhD, Associate Professor at the Dana-Farber Cancer Institute

Dr. Anthony Letai, MD, PhD, Associate Professor at the Dana-Farber Cancer Institute

 Dr. Christopher Kemp, PhD, Member, Human Biology and Public Health Sciences divisions, Fred Hutchinson Cancer Research Center

Dr. Christopher Kemp, PhD, Member, Human Biology and Public Health Sciences divisions, Fred Hutchinson Cancer Research Center

 Dr. Michael Churchill, PhD, Lead Scientist at SEngine Precision Medicine

Dr. Michael Churchill, PhD, Lead Scientist at SEngine Precision Medicine

 Dr. Carla Grandori, MD, PhD, CEO of SEngine Precision Medicine and President and Scientific Director of Cure First

Dr. Carla Grandori, MD, PhD, CEO of SEngine Precision Medicine and President and Scientific Director of Cure First

 Dr. Marc Loriaux, MD, PhD, Associate Professor of Pathology, School of Medicine at OHSU

Dr. Marc Loriaux, MD, PhD, Associate Professor of Pathology, School of Medicine at OHSU

 

Moderator

 Dr. V.K. Gadi, MD, PhD, Associate Member of the Fred Hutchinson Cancer Research Center Clinical Research

Dr. V.K. Gadi, MD, PhD, Associate Member of the Fred Hutchinson Cancer Research Center Clinical Research

Goals of the Evening

•To gain an understanding of next generation precision medicine

•Provide an update on SEngine’s P.A.R.I.S. Test and benefit to patients

•Understanding the role community oncologists play in precision medicine


Sponsors